Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 195.35

-0.8%

Dec 2 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (16243)	3/2/1998 8:37:00 PM
From: Proton	Read Replies (2) of 32384

Re: NBC Story on HER2 GNE initiated trials to treat HER2+ (the sequenced the original gene) patients and the report indicated that a subset of the treated population responded (I think with tumor shrinkage and again the patient showed on the new cast had exceptionally good results). Thanks for an interesting backgrounder on HER2. It will be interesting to see if Genentech gets a pop on this report. Just enough to get the on-line IRA crowd shooting off orders. Which networks are continuing coverage into the week? Pý

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next